SAIRA RAMASASTRY - Corporate Board Profile

SANGAMO THERAPEUTICS, INC

Filing Date	Source Excerpt
2012-04-25	Saira Ramasastry, age 36, is a new director nominee who, since 2009, has periodically worked as a financial and business development consultant for Sangamo. ... Ms. Ramasastry's extensive experience in global healthcare investment banking and strategic advisory consulting provides valuable financial, commercial assessment and business development skills to the Board.
2013-04-25	Saira Ramasastry, age 37, has served as a member of our Board of Directors since June 2012... The Audit Committee currently consists of four directors: Mr. Cleveland, Dr. Dilly, Dr. Mento and Ms. Ramasastry... The Clinical Review Committee currently consists of three directors: Dr. Dilly, Mr. Lanphier and Ms. Ramasastry... The following table sets forth certain information regarding the compensation of each non-employee director for service as a member of the Board of Directors during 2012. Saira Ramasastry. 21,250 Fees Earned or Paid in Cash, 176,990 Option Awards, Total 198,240.
2014-03-11	Saira Ramasastry, age 38, has served as a member of our Board of Directors since June 2012. Ms. Ramasastry currently serves on the boards of directors of Pain Therapeutics, Inc., Repros Therapeutics Inc. and the American Liver Foundation. The Audit Committee currently consists of four directors: Mr. Cleveland, Dr. Dilly, Dr. Mento and Ms. Ramasastry. The Clinical Review Committee currently consists of three directors: Dr. Dilly, Mr. Lanphier and Ms. Ramasastry.
2015-04-28	Saira Ramasastry, age 39, has served as a member of our Board of Directors since June 2012. The Audit Committee currently consists of three directors: Mr. Cleveland, Ms. Parker and Ms. Ramasastry. Director compensation table shows total compensation of $128,310.
2016-04-25	Saira Ramasastry, age 40, has served as a member of our Board of Directors since June 2012. ... The Audit Committee currently consists of three directors: Mr. Cleveland, Ms. Parker and Ms. Ramasastry. ... Saira Ramasastry Fees Earned or Paid in Cash ($) 50,000, Option Awards ($) 65,223, Total ($) 115,223.
2017-04-25	Saira Ramasastry, age 41, has served as a member of our Board of Directors since June 2012... The Audit Committee consists of three directors: Mr. Carey, Mr. Ringo and Ms. Ramasastry.
2018-04-24	Saira Ramasastry, age 42, has served as a member of our Board of Directors since June 2012. The Audit Committee consists of three directors: Mr. Carey, Ms. Ramasastry, and Mr. Zakrzewski. The following table sets forth certain information regarding the compensation of each non-employee director for service as a member of the Board of Directors during 2017. Saira Ramasastry: Total $95,718.
2019-04-25	Saira Ramasastry, age 43, has served as a member of our Board of Directors since June 2012. The Audit Committee consists of three directors: Mr. Carey, Ms. Ramasastry, and Mr. Zakrzewski. Director compensation table shows total compensation of $240,270.
2020-04-02	Saira Ramasastry, age 44, has served as a member of our Board of Directors since June 2012. The Audit Committee consists of three directors: Mr. Carey, Dr. Dilly and Ms. Ramasastry. Ms. Ramasastry received total compensation of $166,312.
2021-04-02	Saira Ramasastry, age 45, has served as a member of our Board of Directors since June 2012. Since 2009, she has served as Managing Partner of Life Sciences Advisory, LLC, a company that she founded to provide strategic advice, business development solutions and innovative financing strategies for the life science industry. Ms. Ramasastry also serves on the Industry Advisory Board of the Michael J. Fox Foundation for Parkinson’s Research and as business and sustainability lead for the European Prevention of Alzheimer’s Dementia consortium. From 1999 to 2009, Ms. Ramasastry was an investment banker with Merrill Lynch & Co., Inc. where she helped establish the biotechnology practice and was responsible for origination of mergers and acquisitions, or M&A, strategic and capital markets transactions. Prior to joining Merrill Lynch, she served as a financial analyst in the M&A group at Wasserstein Perella & Co., an investment banking firm, from 1997 to 1998. Ms. Ramasastry currently serves on the board of directors of Vir Biotechnology, Inc., a public biotechnology company, Glenmark Pharmaceuticals, Ltd., a public pharmaceutical company, and Akouos, Inc., a public genetic medicine company. Ms. Ramasastry previously served on the board of directors of Innovate Biopharmaceuticals, Inc. (now 9 Meters Biopharma, Inc.), a public biopharmaceutical company, from June 2018 to March 2020, and Cassava Sciences, Inc., a public biopharmaceutical company, from February 2013 to June 2020. Ms. Ramasastry received her B.A. in economics with honors and distinction and an M.S. in management science and engineering from Stanford University, as well as an M. Phil. in management studies from the University of Cambridge where she is a guest lecturer for the Bioscience Enterprise Programme and serves on the Cambridge Judge Business School Advisory Council. Ms. Ramasastry is also a Health Innovator Fellow of the Aspen Institute and a member of the Aspen Global Leadership Network. The Nominating and Corporate Governance Committee and the Board believe that Ms. Ramasastry’s extensive experience in global healthcare investment banking and strategic advisory consulting provides valuable financial, commercial assessment and business development skills to the Board and her thorough understanding of our technology and programs provides the Board with valuable insight in the development of our novel genomic and cell therapy assets. The Audit Committee consists of three directors: Mr. Carey, Mr. Meyers and Ms. Ramasastry. Mr. Carey serves as the Chair of this committee. Ms. Ramasastry received total compensation of $290,172 in 2020.
2022-04-01	The Audit Committee consists of three directors: Mr. Carey, Mr. Meyers and Ms. Ramasastry. Ms. Ramasastry is not standing for re-election to the Board of Directors, and her term will expire at the conclusion of the Annual Meeting. The following table sets forth certain information regarding the compensation of each non-employee director for service as a member of the Board of Directors during 2021. Ms. Ramasastry total compensation was $263,062.